Carla R Schubert1, Karen J Cruickshanks2, Mary E Fischer1, Barbara E K Klein1, Ronald Klein1, A Alex Pinto1. 1. Department of Ophthalmology & Visual Sciences, University of Wisconsin-Madison, Madison, WI, USA. 2. Department of Ophthalmology & Visual Sciences, University of Wisconsin-Madison, Madison, WI, USA Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Abstract
BACKGROUND: the incidence of olfactory impairment increases sharply in the eighth and ninth decades of life but the aetiology of age-related olfactory decline is not well understood. Inflammation and atherosclerosis are associated with many age-related conditions and atherosclerosis has been associated with olfactory decline in middle-aged adults. OBJECTIVE: to determine if inflammatory markers and atherosclerosis are associated with the development of olfactory impairment in older adults. DESIGN: longitudinal, population-based study. SETTING/PARTICIPANTS: a total of 1,611 participants, aged 53-97 years in the Epidemiology of Hearing Loss Study without olfactory impairment at the 1998-2000 examination and with follow-up at a subsequent examination 5 and/or 10 years later. METHODS: the San Diego Odor Identification Test was used to measure olfaction. High sensitivity C-reactive protein, interleukin-6 and tumour necrosis factor-α were measured in serum and carotid ultrasound images were obtained for the measurement of carotid intima media thickness (IMT) and plaque assessment. Medical history, behavioural and lifestyle information were obtained by interview. RESULTS: inflammatory markers, IMT and plaque were not associated with the 10-year cumulative incidence of olfactory impairment in adjusted Cox proportional hazard models. Among those <60 years, the mean IMT [hazard ratio (HR) = 4.35, 95% confidence interval (CI) = 1.69-11.21, tertile 3 versus tertile 1] and the number of sites with plaque (HR = 1.56, 95% CI = 1.17-2.08, per site) were associated with an increased risk of developing an olfactory impairment at follow-up. CONCLUSION: subclinical atherosclerosis at a younger age may be a risk factor for the development of olfactory impairment.
BACKGROUND: the incidence of olfactory impairment increases sharply in the eighth and ninth decades of life but the aetiology of age-related olfactory decline is not well understood. Inflammation and atherosclerosis are associated with many age-related conditions and atherosclerosis has been associated with olfactory decline in middle-aged adults. OBJECTIVE: to determine if inflammatory markers and atherosclerosis are associated with the development of olfactory impairment in older adults. DESIGN: longitudinal, population-based study. SETTING/PARTICIPANTS: a total of 1,611 participants, aged 53-97 years in the Epidemiology of Hearing Loss Study without olfactory impairment at the 1998-2000 examination and with follow-up at a subsequent examination 5 and/or 10 years later. METHODS: the San Diego Odor Identification Test was used to measure olfaction. High sensitivity C-reactive protein, interleukin-6 and tumour necrosis factor-α were measured in serum and carotid ultrasound images were obtained for the measurement of carotid intima media thickness (IMT) and plaque assessment. Medical history, behavioural and lifestyle information were obtained by interview. RESULTS: inflammatory markers, IMT and plaque were not associated with the 10-year cumulative incidence of olfactory impairment in adjusted Cox proportional hazard models. Among those <60 years, the mean IMT [hazard ratio (HR) = 4.35, 95% confidence interval (CI) = 1.69-11.21, tertile 3 versus tertile 1] and the number of sites with plaque (HR = 1.56, 95% CI = 1.17-2.08, per site) were associated with an increased risk of developing an olfactory impairment at follow-up. CONCLUSION: subclinical atherosclerosis at a younger age may be a risk factor for the development of olfactory impairment.
Authors: Nancy E Rawson; George Gomez; Beverly J Cowart; Andres Kriete; Edmund Pribitkin; Diego Restrepo Journal: Neurobiol Aging Date: 2011-11-09 Impact factor: 4.673
Authors: Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor Journal: Circulation Date: 2003-01-28 Impact factor: 29.690
Authors: Carla R Schubert; Karen J Cruickshanks; Mary E Fischer; Guan-Hua Huang; Ronald Klein; Michael Y Tsai; A Alex Pinto Journal: J Gerontol A Biol Sci Med Sci Date: 2014-09-02 Impact factor: 6.053
Authors: Claire Murphy; Carla R Schubert; Karen J Cruickshanks; Barbara E K Klein; Ronald Klein; David M Nondahl Journal: JAMA Date: 2002-11-13 Impact factor: 56.272
Authors: Mary E Fischer; Karen J Cruickshanks; Carla R Schubert; Alex A Pinto; Cynthia M Carlsson; Barbara E K Klein; Ronald Klein; Ted S Tweed Journal: J Am Geriatr Soc Date: 2016-09-09 Impact factor: 5.562
Authors: Janina Seubert; Erika J Laukka; Debora Rizzuto; Thomas Hummel; Laura Fratiglioni; Lars Bäckman; Maria Larsson Journal: J Gerontol A Biol Sci Med Sci Date: 2017-08-01 Impact factor: 6.053
Authors: Ingrid Ekström; Maria Larsson; Debora Rizzuto; Johan Fastbom; Lars Bäckman; Erika J Laukka Journal: J Gerontol A Biol Sci Med Sci Date: 2020-11-13 Impact factor: 6.053
Authors: Carla R Schubert; Mary E Fischer; A Alex Pinto; Barbara E K Klein; Ronald Klein; Ted S Tweed; Karen J Cruickshanks Journal: J Gerontol A Biol Sci Med Sci Date: 2017-05-01 Impact factor: 6.053
Authors: Victoria Van Regemorter; Thomas Hummel; Flora Rosenzweig; André Mouraux; Philippe Rombaux; Caroline Huart Journal: Front Neurosci Date: 2020-02-21 Impact factor: 4.677